Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 5873 - 5880 of 12008 results
TCPA Regulatory Update: FCC Evaluates Comments Received in Several TCPA Proceedings
July 18, 2018| Article| Viewpoint
TCPA Class Action Update: Post ACA International, the TCPA’s Autodialer Definition Is Restricted to a Device’s Current Functions
July 18, 2018| Article| Viewpoint
Court of Appeals Weighs in on 340B
July 18, 2018| Blog| Viewpoint
Recent ITC decision clarifies and eases domestic industry burden for patent holders
July 17, 2018| Blog| Viewpoint
July 2018: Where Are We Now With 340B?
July 17, 2018| Blog| Viewpoint
MintzEdge Entrepreneur Perspective: “Reinventing the Resume” - Co-Founders of Skillist
July 17, 2018| Podcast| Viewpoint
Retrogression of Employment Based First Preference Priority Date on August 1, 2018
July 16, 2018| Alert| Viewpoint
The Potential Pitfalls of Contesting Arbitrability in the Arbitration
July 16, 2018| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|